Summary & Overview
CPT 68525: Lacrimal Sac Biopsy, Nasolacrimal Duct
Headline: CPT code 68525: Lacrimal Sac Biopsy Gains Clinical Attention
CPT code 68525 denotes a surgical biopsy of the lacrimal sac (the upper dilated end of the nasolacrimal duct) to obtain tissue for diagnostic pathology. The code captures a focused ocular diagnostic procedure performed by ophthalmologists or oculoplastic surgeons when clinical concern exists for infection, chronic inflammation, or malignancy of the tear drainage apparatus. Nationally, precise coding for this procedure supports clinical decision-making, appropriate site-of-service classification, and accurate claims processing for relatively infrequent but clinically significant interventions.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and typical sites of service, billing and coding considerations relevant to payers listed above, and benchmarking themes where available. The publication outlines where this code fits within procedural portfolios for ophthalmology and oculoplastic surgery and summarizes common documentation elements needed to justify medical necessity.
This piece is intended for billing managers, practice administrators, and clinicians seeking a concise national briefing on CPT code 68525, including clinical purpose, coverage landscape, and areas to review in payer contracts and internal billing workflows.
Billing Code Overview
CPT code 68525 describes a biopsy of the lacrimal sac, the upper dilated portion of the nasolacrimal duct. The procedure involves obtaining tissue from the lacrimal sac for histopathologic evaluation to diagnose inflammatory, infectious, or neoplastic processes affecting the tear drainage system.
Service Type: Surgical biopsy / Diagnostic ocular procedure
Typical Site of Service: Ophthalmology clinic or ambulatory surgical center, and may also be performed in a hospital outpatient setting when clinically indicated.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 65-year-old woman referred to an oculoplastic surgeon by an ophthalmologist for persistent unilateral epiphora (tearing), recurrent dacryocystitis, or a lacrimal sac mass noted on exam or imaging. Prior evaluation includes history, external inspection, fluorescein dye disappearance testing, and lacrimal irrigation demonstrating an obstructed nasolacrimal duct or a palpable lacrimal sac abnormality. Imaging such as dacryocystography or orbital CT may suggest focal sac wall thickening or tumor. The clinical workflow begins with informed consent and preoperative assessment, local or monitored anesthesia is administered in an ambulatory surgical center or hospital outpatient department, and the surgeon exposes the lacrimal sac through a small external or endoscopic approach. A targeted biopsy of the lacrimal sac mucosa or suspicious lesion is obtained using forceps or curettage, hemostasis is achieved, specimens are submitted to pathology with appropriate labeling, and the patient is observed for immediate complications (bleeding, infection). Postoperative instructions include wound care, antibiotic or steroid therapy as indicated, and follow-up for pathology results to guide further management (definitive oncologic treatment, dacryocystorhinostomy if indicated, or observation). Typical site of service: ambulatory surgical center or hospital outpatient department. Service type: surgical biopsy of lacrimal sac (diagnostic/operative ophthalmic procedure).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |